During a press event focused on maternal healthcare, US President Donald Trump made a sensational claim that an unnamed drug could revive individuals who have died. He recounted a specific case where a patient, after being given last rites, was treated with this drug and subsequently improved. Trump made these remarks while discussing the Right to Try Act, which permits terminally ill patients to seek experimental treatments that have not yet received full approval from the Food and Drug Administration (FDA). He noted that while some drugs may not be effective, the testing process is crucial, emphasizing the need for rigorous evaluation. In addition to these claims, Trump highlighted his administration's initiative to lower drug prices through the launch of TrumpRx.gov, a platform that offers access to over 750 medications, including both brand-name and generic options, aimed at enhancing affordability and accessibility for consumers. The president's statements have sparked discussions about the implications of such claims and the ongoing efforts to reform drug pricing in the United States.